Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.39 and traded as low as $0.28. Northwest Biotherapeutics shares last traded at $0.29, with a volume of 1,782,919 shares changing hands.
Northwest Biotherapeutics Trading Up 4.8 %
The business’s fifty day moving average price is $0.31 and its 200-day moving average price is $0.39. The company has a market capitalization of $361.14 million, a P/E ratio of -4.19 and a beta of -0.58.
Northwest Biotherapeutics (OTCMKTS:NWBO – Get Free Report) last issued its quarterly earnings results on Friday, August 9th. The biotechnology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.51 million during the quarter.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
See Also
- Five stocks we like better than Northwest Biotherapeutics
- What Are Dividend Contenders? Investing in Dividend Contenders
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How to Invest in Biotech Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Transportation Stocks Investing
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
